Anaplastic Astrocytoma — Trials

Anaplastic Astrocytoma — Trials · CancerIndex

Clinical trials

Registered studies

209 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 37
Recruiting: 22
Ph III recruiting: 2
Growth YoY: —
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 41.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (45)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01837862	A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas	active not recruiting	Phase 1 / Phase 2	10	Julie KrystalOTHER	1	Aug 6, 2026	clinicaltrials
NCT03180502	Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma	active not recruiting	Phase 2	120	NRG OncologyOTHER	1	Jul 28, 2026	clinicaltrials